Auransa’s AI-predicted pipeline

How Auransa is using AI to uncover and treat new patient subgroups

Auransa Inc. has built a predictive AI-based discovery engine that analyzes patient-derived data to identify and develop the right compound for each patient subpopulation in less time than traditional discovery methods.

“The engine unbiasedly reveals the heterogeneity that is contained in a disease,” co-founder and CEO Pek Lum told BioCentury.

Auransa feeds its SubtypesMarkersTargetsRedefining (SMarTR) engine patient data from public databases, overlaying

Read the full 617 word article

User Sign In